Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study
ConclusionPrior CEVD was associated with a significantly increased risk of 10 year all-cause death which was similar in patients treated with PCI or CABG. These results do not support preferential referral for PCI rather than CABG in patients with prior CEVD.Trial registration: SYNTAX: ClinicalTrials.gov reference: NCT00114972. SYNTAX Extended Survival: ClinicalTrials.gov reference: NCT03417050.Graphic abstract
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
More News: Angioplasty | Cardiology | Chronic Obstructive Pulmonary | Congestive Heart Failure | Coronary Angioplasty | Coronary Artery Bypass Graft | Diabetes | Endocrinology | Heart | Heart Failure | Insulin | Metabolic Syndrome | Percutaneous Coronary Intervention | Peripheral Vascular Disease (PVD) | Stroke | Study